RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

Tian-Hao Weng(First Affiliated Hospital Zhejiang University), Hangping Yao(First Affiliated Hospital Zhejiang University)
Cancer Research and Treatment
April 22, 2020
Cited by 64


Related Papers